MUB Medical Secures Funding for Pre-clinical Trials

We are thrilled to announce that MUB Medical has received financing from Innovation Norway to conduct pre-clinical trials for Sutrips. This marks the third time that Innovation Norway has supported us financially, and we are incredibly grateful for their ongoing trust and belief in our vision.
With the backing of Innovation Norway, we are now focused on preparing for Sutrips’ global market introduction. We will actively engage with key industry players to explore potential collaborations for the successful launch of Sutrips.
It’s an exhilarating time for us, and we invite you to follow us on LinkedIn for more exciting updates. Stay tuned as we share the remarkable results of our proof of concept, which we recently completed.
Thank you for your unwavering support and enthusiasm as we work towards revolutionizing wound care with Sutrips! A simple Scandinavian solution for a complex global problem.

Ubbat Ocak

Ubbat Ocak is a visionary entrepreneur and the driving force behind MUB Medical Solutions. With a passion for innovation and a deep understanding of the healthcare industry, Ubbat has dedicated himself to revolutionizing wound closure practices. His relentless pursuit of excellence and commitment to making a positive impact have propelled MUB Medical to the forefront of the field. Ubbat's leadership and forward-thinking approach inspire his team to push boundaries and deliver cutting-edge solutions that improve patient outcomes. With his unwavering determination and strategic vision, Ubbat Ocak is shaping the future of wound closure technologies.